ロード中...
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
SIMPLE SUMMARY: Several clinical protocols are exploring the anticancer effect of immunotherapy combined to targeted therapy. Indeed, emerging evidence demonstrates that small-molecule targeted inhibitors promote the antitumor immune response. In the case of mechanistic target of rapamycin (mTOR) in...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002586/ https://ncbi.nlm.nih.gov/pubmed/33802831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061359 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|